indazoles has been researched along with Leiomyosarcoma in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 15 (78.95) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Acar, R; Akgul, F; Artac, M; Aydin, SG; Bahceci, A; Besiroglu, M; Bilici, A; Cinkir, HY; Dal, P; Demir, H; Demiray, AG; Derin, S; Eraslan, E; Erdem, D; Ergun, Y; Erol, C; Goksu, SS; Guc, ZG; Gumusay, O; Gunaydin, UM; Kaplan, MA; Karaagac, M; Karaca, M; Koca, S; Koral, L; Menekse, S; Ocak, B; Ozkul, O; Ozveren, A; Ozyukseler, DT; Paydas, S; Sahin, S; Sakalar, T; Sakin, A; Seker, MM; Sunar, V; Turhal, S; Unal, OU; Yekeduz, E | 1 |
| Guru, PK; Patel, PR; Pereira, ROL; Sanghavi, DK | 1 |
| Bay, JO; Bertucci, F; Bompas, E; Bozec, L; Chenuc, G; Chevreau, C; Cupissol, D; Delaye, J; Delcambre, C; Duffaud, F; Eymard, JC; Guillemet, C; Isambert, N; Italiano, A; Pautier, P; Penel, N; Piperno-Neumann, S; Ray-Coquard, I; Rios, M; Saada, E | 1 |
| Aydın, D; Beşiroğlu, M; Bilici, M; Dane, F; Doğu, GG; Hacıoğlu, B; Kaplan, NB; Karaca, M; Koca, S; Oruç, Z; Özçelik, M | 1 |
| Chao, A; Huang, HJ; Lai, CH; Lee, LY; Lee, YS; Lin, CY; Peng, MT; Tsai, CL; Ueng, SH; Wang, HS; Wu, RC; Yang, LY | 1 |
| Aiello, N; Barra, F; Bogani, G; Ditto, A; Ferrero, S; Leone Roberti Maggiore, U; Lorusso, D; Raspagliesi, F | 1 |
| Benson, C; Freivogel, KW; Gelderblom, H; Grignani, G; Jobanputra, M; Judson, IR; Katz, D; Manson, SC; Merimsky, O; Mungul, A; Sanfilippo, R; Stein, D | 1 |
| Kushnir, I; Merimsky, O; Soyfer, V | 1 |
| Groenland, SL; Huitema, ADR; Katz, D; Steeghs, N | 1 |
| Barra, F; De Cian, F; Di Domenico, S; Ferraioli, D; Ferrero, S; Tantari, M; Vellone, VG | 1 |
| Hsiao, HH; Lin, MH | 1 |
| Skubitz, KM | 1 |
| Araki, N; Boku, S; Goto, T; Hiraga, H; Honoki, K; Kawai, A; Matsumine, A; Nakamura, T; Nishida, Y; Sudo, A; Sugiura, H; Ueda, T; Yasuda, T; Yonemoto, T | 1 |
| Benson, C; Blay, JY; Chawla, S; Dewji, MR; Gil, T; Judson, I; Le Cesne, A; Litière, S; Marréaud, S; Papai, Z; Piperno-Neumann, S; Ray-Coquard, I; Schöffski, P; Sleijfer, S; van der Graaf, WTA | 1 |
| Lee, NR; Lee, SY | 1 |
| Kaneko, T; Shinkai, M; Watanabe, K | 1 |
| Chuman, H; Hayashi, Y; Iwase, H; Kawai, A; Kobayashi, E; Makino, Y; Nakatani, F; Sano, T; Tanzawa, Y | 1 |
| Ebina, Y; Miyamoto, T; Nagamata, S; Nishijima, M; Yamada, H; Yamano, Y | 1 |
| Fader, AN; Ricci, S; Stone, RL | 1 |
3 review(s) available for indazoles and Leiomyosarcoma
| Article | Year |
|---|---|
Pharmacokinetic drug evaluation of pazopanib for the treatment of uterine leiomyosarcomas.
Topics: Angiogenesis Inhibitors; Female; Humans; Indazoles; Leiomyosarcoma; Protein Kinase Inhibitors; Pyrimidines; Sulfonamides; Uterine Neoplasms | 2017 |
Current state of the art and emerging pharmacotherapy for uterine leiomyosarcomas.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Combined Modality Therapy; Doxorubicin; Female; Humans; Indazoles; Leiomyosarcoma; Prognosis; Pyrimidines; Sulfonamides; Uterine Neoplasms | 2019 |
Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Chemotherapy, Adjuvant; Deoxycytidine; Diagnostic Errors; Dioxoles; Docetaxel; Doxorubicin; Female; Gemcitabine; Humans; Hysterectomy; Indazoles; Laparoscopy; Leiomyoma; Leiomyosarcoma; Morcellation; Neoplasm Staging; Pyrimidines; Sulfonamides; Taxoids; Tetrahydroisoquinolines; Trabectedin; Uterine Myomectomy; Uterine Neoplasms | 2017 |
2 trial(s) available for indazoles and Leiomyosarcoma
| Article | Year |
|---|---|
A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study).
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Indazoles; Leiomyosarcoma; Male; Middle Aged; Pyrimidines; Sulfonamides | 2020 |
Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Indazoles; Leiomyosarcoma; Middle Aged; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Retrospective Studies; Sarcoma; Sulfonamides; Survival Rate; Uterine Neoplasms; Young Adult | 2016 |
14 other study(ies) available for indazoles and Leiomyosarcoma
| Article | Year |
|---|---|
Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study.
Topics: Adult; Female; Humans; Indazoles; Leiomyosarcoma; Male; Middle Aged; Neoplasms, Second Primary; Retrospective Studies; Sarcoma; Sarcoma, Synovial; Soft Tissue Neoplasms; Turkey | 2023 |
Tumour-bowel fistula as a possible complication of pazopanib therapy in retroperitoneal leiomyosarcoma.
Topics: Angiogenesis Inhibitors; Diagnosis, Differential; Humans; Indazoles; Intestinal Fistula; Intestinal Perforation; Leiomyosarcoma; Male; Middle Aged; Pyrimidines; Retroperitoneal Neoplasms; Sulfonamides; Tomography, X-Ray Computed | 2019 |
Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study.
Topics: Adult; Female; Humans; Indazoles; Leiomyosarcoma; Male; Middle Aged; Progression-Free Survival; Protein Kinase Inhibitors; Pyrimidines; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Sulfonamides; Survival Analysis | 2021 |
Synergistic effects of pazopanib and hyperthermia against uterine leiomyosarcoma growth mediated by downregulation of histone acetyltransferase 1.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Biomarkers; CLOCK Proteins; Female; Gene Expression Regulation, Neoplastic; Histone Acetyltransferases; Humans; Hyperthermia, Induced; Indazoles; Leiomyosarcoma; Pyrimidines; Sulfonamides; Uterine Neoplasms | 2020 |
Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study
Topics: Angiogenesis Inhibitors; Compassionate Use Trials; Disease-Free Survival; Female; Hemangiosarcoma; Humans; Indazoles; Leiomyosarcoma; Lung Neoplasms; Male; Middle Aged; Pyrimidines; Retrospective Studies; Sarcoma; Sarcoma, Synovial; Solitary Fibrous Tumors; Sulfonamides; Survival Rate; Time Factors; Uterine Neoplasms | 2017 |
A Case Report of Metastatic Primary Thyroid Leiomyosarcoma Treated with Pazopanib.
Topics: Aged; Antineoplastic Agents; Female; Humans; Indazoles; Leiomyosarcoma; Neoplasm Metastasis; Pyrimidines; Sulfonamides; Thyroid Neoplasms | 2018 |
Harnessing soft tissue sarcoma with low-dose pazopanib - a matter of blood levels.
Topics: Aged; Angiogenesis Inhibitors; Dose-Response Relationship, Drug; Female; Humans; Indazoles; Leiomyosarcoma; Male; Middle Aged; Protein Kinase Inhibitors; Pyrimidines; Soft Tissue Neoplasms; Sulfonamides | 2018 |
Promising effects of pazopanib with radiation on an advanced prostate leiomyosarcoma after failure of systemic chemotherapy.
Topics: Antineoplastic Agents; Combined Modality Therapy; Gamma Rays; Humans; Indazoles; Leiomyosarcoma; Male; Middle Aged; Prostate; Prostatic Neoplasms; Pyrimidines; Sulfonamides; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
Cardiotoxicity Monitoring in Patients Treated with Tyrosine Kinase Inhibitors.
Topics: Aged; Carcinoma, Renal Cell; Female; Heart Failure; Humans; Indazoles; Kidney Neoplasms; Leiomyosarcoma; Middle Aged; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Sulfonamides; Sunitinib | 2019 |
The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Chemical and Drug Induced Liver Injury; Disease-Free Survival; Female; Fibrosarcoma; Humans; Hypertension; Indazoles; Japan; Leiomyosarcoma; Liposarcoma; Male; Middle Aged; Neoplasm Recurrence, Local; Neurilemmoma; Pneumothorax; Product Surveillance, Postmarketing; Pyrimidines; Retrospective Studies; Sarcoma; Sarcoma, Synovial; Sulfonamides; Survival Analysis; Thrombocytopenia | 2016 |
Positive response of a primary leiomyosarcoma of the breast following salvage hyperthermia and pazopanib.
Topics: Breast Neoplasms; Female; Humans; Hyperthermia, Induced; Indazoles; Leiomyosarcoma; Middle Aged; Pyrimidines; Sulfonamides | 2018 |
Autopsy case of pulmonary artery sarcoma forming aneurysm without FDG uptake.
Topics: Adult; Aneurysm; Aneurysm, Ruptured; Fatal Outcome; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Indazoles; Leiomyosarcoma; Lung; Male; Neoplasm Invasiveness; Positron-Emission Tomography; Pulmonary Artery; Pyrimidines; Radiopharmaceuticals; Rupture, Spontaneous; Shock, Hemorrhagic; Sulfonamides; Vascular Neoplasms | 2016 |
[A Case of Severe Hematological Toxicity in Response to Pazopanib].
Topics: Angiogenesis Inducing Agents; Female; Humans; Indazoles; Leiomyosarcoma; Middle Aged; Neutropenia; Pyrimidines; Recurrence; Retroperitoneal Neoplasms; Sulfonamides; Thrombocytopenia | 2016 |
A Case of Uterine Leiomyosarcoma with Long-Term Disease Control by Pazopanib.
Topics: Antineoplastic Agents; Female; Humans; Indazoles; Leiomyosarcoma; Lung Neoplasms; Middle Aged; Protein Kinase Inhibitors; Pyrimidines; Salvage Therapy; Sulfonamides; Tomography, X-Ray Computed; Uterine Neoplasms | 2016 |